Acoustic Medicine And Ultrasound Therapy Market Size

Acoustic Medicine And Ultrasound Therapy Market Analysis

The acoustic medicine and ultrasound therapy market studied is anticipated to register a CAGR of nearly 4.1% during the forecast period.

• COVID-19 had a significant impact on the studied market initially, as there were few research and development activities regarding the usage of ultrasound therapy in COVID-19-infected patients. For instance, in May 2021, a few researchers at the University of California of San Diego School of Medicine began a pilot clinical trial to test the efficacy of using ultrasound therapy to stimulate the spleen and reduce COVID-19-related inflammation, which helped to decrease the length of hospital stays. Thus, the pandemic initially affected the market of acoustic medicine and ultrasound therapy services. However, as the pandemic has subsided, acoustic medicine and ultrasound therapy are taking place normally; hence, the studied market is likely to have favorable growth in the coming years.
• Certain factors that are driving the market growth include an increase in the number of incidences of sports injuries and bone disorders and the rising interest of people in natural methods of medication. Sports injuries include strains and sprains, spondylolysis and spondylolisthesis, stingers, disc injury, and Scheuermann's disease. For instance, according to the data published by the National Safety Council of the United States in 2021, it is estimated that around 3.2 million people were treated in emergency departments for injuries involving sports and recreational equipment in the United States in 2021. The most common activities that were frequently associated with injuries were exercise, cycling, and basketball. The injury rate for exercise was 123.8 per 100,000 population in the United States in 2021. For bicycles and accessories, it was 113.7, and for basketball, it was 78.6.
• Furthermore, in 2022, as per the United Nations Report, World Population Ageing 2022: Highlights report, it was estimated that 10% of the overall global population is aged 65 years and older. The geriatric population is expected to reach 16% by 2050. This is anticipated to drive the market for therapeutic ultrasound devices during the forecast period as the geriatric population is more prone to diseases such as rheumatoid arthritis and osteoarthritis, which makes acoustic medicine and ultrasound therapy a favorable treatment option.
• Furthermore, in April 2023, an estimated 20.9% of United States adults, or 51.6 million persons, experienced chronic pain in 2021, and 6.9%, or 17.1 million persons, experienced high-impact chronic pain, which means chronic pain that results in a substantial restriction to daily activities. Conditions such as arthritis, lower back pain, joint pain, muscle pain, and fibromyalgia are patients' major causes of chronic pain. The innovation in wearable ultrasound therapy devices allows for pain relief treatment to take place at home. This reduces the costs associated with a regular hospital or clinic visits. The device emits ultrasound waves that squeeze and open tissues, increasing the movement of nutrients. This speeds up the healing process and creates a soothing effect for the patient, thereby reducing the pain experienced by them drastically. The benefits and the convenience of such devices are driving the demand, especially in high-income regions of North America and Europe.
• Thus, the aforementioned factors, such as the rising prevalence of sports injuries, the rising geriatric population, and the benefits and convenience of acoustic medicine and ultrasound therapy devices, are expected to boost market growth. However, the lack of knowledge and awareness is expected to hinder the growth of the market.